Henry Schein, Northwell Health Dedicate Oral Health Navigator Programme for Young Cancer Patients

Henry Schein Cares Foundation funds programme with $90,000 donation; dedication takes place during ribbon cutting of new dental operatory supported by company’s $250,000 donation of healthcare products and equipment

From left is Joseph Brodsky, DMD; Gerry Benjamin of Henry Schein; Jeffrey Lipton, MD; Michael J. Dowling, President and CEO of Northwell Health; Stanley M. Bergman, Chairman of the Board and CEO of Henry Schein; Ronald Burakoff, DMD, MPH; Charles Schleien, MD; and Steve Kess and Howie Stapler of Henry Schein. (PRNewsFoto/Henry Schein, Inc.)

Henry Schein, Inc. joined Northwell Health to officially dedicate the Henry Schein Oral Health Navigator Programme, an innovative initiative designed to help young patients avoid oral health-related complications during cancer treatment. The programme is based at Cohen Children’s Medical Centre of New York, a leading provider of paediatric oncology care and a part of the Northwell system.

As part of the programme, the Henry Schein Cares Foundation, Inc. is donating $30,000 per year for three consecutive years to help fund the position of an “Oral Health Navigator”, a dedicated Patient Service Assistant who helps young patients who are fighting cancer create a plan to improve their oral health. Poor oral health can complicate and even delay the provision of cancer treatment. To avoid that outcome, the Oral Health Navigator facilitates a plan to achieve optimal oral health for each patient by working closely with haematologists, oncologists and dentists through diagnosis, evaluation and treatment.

The programme was dedicated during the ribbon cutting of a new dental operatory within the medical centre for which Henry Schein donated more than $250,000 in health care products and equipment, including the latest in digital technology. The donation is an initiative of Henry Schein Cares, the company’s global corporate social responsibility programme.

“Henry Schein is pleased to partner with the visionary healthcare professionals at Cohen Children’s Medical Centre to benefit one of our most vulnerable populations – children fighting cancer,” said Mr. Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. “This program further underscores the link between oral health and total health, and we applaud the team at Cohen Children’s Medical Centre for launching this innovative approach to advancing overall health for cancer patients. We look forward to working closely with the dedicated team at the Cohen Children’s Medical Centre for years to come.”

Henry Schein has a decade-long history of involvement with Cohen Children’s Medical Centre. In 2006, the company launched the Henry Schein Cares Comfort Cart at Cohen (then known as Schneider Children’s Hospital). Stocked with items such as toothbrushes, toothpaste, shampoo and deodorant, as well as books, games and other items, the cart makes unexpected stays more pleasant for parents and siblings of hospitalised children. In addition, Henry Schein partnered with Cohen in 2014 to provide multi-year financial support for Cohen’s Child Life Programme. The Child Life Programme offers a broad array of services to paediatric patients and their families, including developmentally appropriate recreation; medical education, play and preparation; procedural support; and art and music therapy.

“Our continuing partnership with Henry Schein has played a significant role in enhancing the quality of care we provide to our patients,” said Charles Schleien, MD, Senior Vice President, Executive Director, Cohen Children’s Medical Centre. “With the addition of the Henry Schein Oral Health Navigator Programme and its generous donation of dental supplies and equipment, we will be able to better support our staff of board-certified paediatric dentists who will be able to work more efficiently with our cancer experts in treating the many children seen at Cohen every year. We recognise the importance of good oral health as a key contributor to effective cancer treatment, and we thank Henry Schein for their continued support.”